Pearl Pathways has hired Cara Frosch as director of business development. She has more than 35 years of diversified biopharmaceutical and medical device experience in human and animal health. After a short stint in clinical practice as a physician assistant, Frosch held roles of increasing responsibility in virtually every phase of product development, from diagnostic assay development and global regulatory affairs to clinical research operations and corporate strategic planning.

Her career includes considerable leadership experience across small and large sponsor companies including Abbott, BioVeris, and MedImmune. Most recently, Frosch spent 12 years at Eli Lilly and Co. / Elanco, where she led new product planning, global portfolio, and market intelligence initiatives. In the service provider sector, she served as VP of clinical trial management for a global staff of more than 300 at a global clinical research organization.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}